Literature DB >> 27577569

Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine.

Poupak Fallahi1, Silvia Martina Ferrari1, Santino Marchi2, Nicola De Bortoli2, Ilaria Ruffilli1, Alessandro Antonelli3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27577569     DOI: 10.1007/s12020-016-1090-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  20 in total

Review 1.  When thyroid hormone replacement is ineffective?

Authors:  Salvatore Benvenga
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-10       Impact factor: 3.243

2.  Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis.

Authors:  Marco Centanni; Lucilla Gargano; Gianluca Canettieri; Nicola Viceconti; Antonella Franchi; Gianfranco Delle Fave; Bruno Annibale
Journal:  N Engl J Med       Date:  2006-04-27       Impact factor: 91.245

3.  Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism.

Authors:  Davide Brancato; Alessandro Scorsone; Gabriella Saura; Lidia Ferrara; Anna Di Noto; Vito Aiello; Mattia Fleres; Vincenzo Provenzano
Journal:  Endocr Pract       Date:  2014-07       Impact factor: 3.443

4.  Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association.

Authors:  M Centanni; M Marignani; L Gargano; V D Corleto; A Casini; G Delle Fave; M Andreoli; B Annibale
Journal:  Arch Intern Med       Date:  1999 Aug 9-23

Review 5.  The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption.

Authors:  Marek Ruchała; Ewelina Szczepanek-Parulska; Ariadna Zybek
Journal:  Endokrynol Pol       Date:  2012       Impact factor: 1.582

6.  Decrease in TSH levels after lactose restriction in Hashimoto's thyroiditis patients with lactose intolerance.

Authors:  Mehmet Asik; Fahri Gunes; Emine Binnetoglu; Mustafa Eroglu; Neslihan Bozkurt; Hacer Sen; Erdem Akbal; Coskum Bakar; Yavuz Beyazit; Kubilay Ukinc
Journal:  Endocrine       Date:  2014-06       Impact factor: 3.633

7.  Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Poupak Fallahi; Massimiliano Cazzato; Silvia Martina Ferrari; Marco Sebastiani; Ele Ferrannini
Journal:  Eur J Endocrinol       Date:  2007-04       Impact factor: 6.664

8.  Celiac disease presenting as resistant hypothyroidism.

Authors:  J H McDermott; A Coss; C H Walsh
Journal:  Thyroid       Date:  2005-04       Impact factor: 6.568

9.  Lactose intolerance revealed by severe resistance to treatment with levothyroxine.

Authors:  Manuel Muñoz-Torres; Mariela Varsavsky; Guillermo Alonso
Journal:  Thyroid       Date:  2006-11       Impact factor: 6.568

10.  Altered intestinal absorption of L-thyroxine caused by coffee.

Authors:  Salvatore Benvenga; Luigi Bartolone; Maria Angela Pappalardo; Antonia Russo; Daniela Lapa; Grazia Giorgianni; Giovanna Saraceno; Francesco Trimarchi
Journal:  Thyroid       Date:  2008-03       Impact factor: 6.568

View more
  11 in total

Review 1.  Novel thyroxine formulations: a further step toward precision medicine.

Authors:  Camilla Virili; Pierpaolo Trimboli; Marco Centanni
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

2.  Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.

Authors:  Rosarita Ferrara; Valentina Ientile; Vincenzo Arcoraci; Carmen Ferrajolo; Carlo Piccinni; Andrea Fontana; Salvatore Benvenga; Gianluca Trifirò
Journal:  Endocrine       Date:  2017-02-02       Impact factor: 3.633

3.  Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.

Authors:  Salvatore Benvenga; Flavia Di Bari; Roberto Vita
Journal:  Endocrine       Date:  2017-02-03       Impact factor: 3.633

4.  Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis.

Authors:  Camilla Virili; Luca Giovanella; Poupak Fallahi; Alessandro Antonelli; Maria Giulia Santaguida; Marco Centanni; Pierpaolo Trimboli
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-26       Impact factor: 5.555

5.  Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Gabriele Materazzi; Francesca Ragusa; Ilaria Ruffilli; Armando Patrizio; Paolo Miccoli; Alessandro Antonelli
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-10-03

Review 6.  Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution.

Authors:  Salvatore Benvenga; Allan Carlé
Journal:  Adv Ther       Date:  2019-09-04       Impact factor: 3.845

Review 7.  Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient's Lifetime.

Authors:  Leonidas H Duntas; Jacqueline Jonklaas
Journal:  Adv Ther       Date:  2019-09-04       Impact factor: 3.845

8.  Liquid and softgel capsules of l-thyroxine results lower serum thyrotropin levels more than tablet formulations in hypothyroid patients.

Authors:  Salvatore Benvenga
Journal:  J Clin Transl Endocrinol       Date:  2019-08-06

Review 9.  L-T4 Therapy in Enteric Malabsorptive Disorders.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Giusy Elia; Francesca Ragusa; Sabrina Rosaria Paparo; Alessandro Antonelli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-23       Impact factor: 5.555

Review 10.  The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.

Authors:  Alessandro Antonelli; Giusy Elia; Francesca Ragusa; Sabrina Rosaria Paparo; Gabriella Cavallini; Salvatore Benvenga; Silvia Martina Ferrari; Poupak Fallahi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.